This content is Free Access.
Screening multiparametrico di farmaci organoidi tumorali mediante imaging a cellule vive a campo ampio per analisi di massa e organoidi singoli
4,146 Views
•
12:41 min
•
December 23, 2022
DOI:
1Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON),University of Antwerp, 2Industrial Vision Lab,University of Antwerp, 3Department of Hepatobiliary Transplantation and Endocrine Surgery,University Hospital Antwerp (UZA), 4Department of Oncology,University Hospital Antwerp (UZA), 5Plasma Lab for Applications in Sustainability and Medicine ANTwerp (PLASMANT),University of Antwerp
概要
Automatically generated
Questo protocollo descrive un metodo semi-automatico per screening di farmaci organoidi a medio-alto rendimento e un software di analisi delle immagini automatizzato indipendente dal microscopio per quantificare e visualizzare risposte multiparametriche a singolo organoide per catturare l'eterogeneità intratumorale.
Explore More Videos
MultiparametricTumor OrganoidDrug ScreeningLive-cell ImagingBulk AnalysisSingle-organoid AnalysisStreamlined WorkflowAutomated AnalysisClinically RelevantPatient-derived Tumor OrganoidsPDTOExtracellular MatrixECMDissociationCell SuspensionPDAC OrganoidCulture MediumCell PlatingECM DomesY-27632Organoid Harvesting
Read Article
Cite this Article
Le Compte, M., Cardenas De La Hoz, E., Peeters, S., Smits, E., Lardon, F., Roeyen, G., Vanlanduit, S., Prenen, H., Peeters, M., Lin, A., Deben, C. Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis. J. Vis. Exp. (190), e64434, doi:10.3791/64434 (2022).
Copy